Clemens W.G.M. Löwik
Erasmus MC Cancer Institute(NL)
Publications by Year
Research Areas
Bone health and treatments, Nanoplatforms for cancer theranostics, Photodynamic Therapy Research Studies, Bone Metabolism and Diseases, TGF-β signaling in diseases
Most-Cited Works
- → Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation(2005)957 cited
- → Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist(2004)880 cited
- → The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery(2011)795 cited
- → Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A(2002)613 cited
- → BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis(2007)537 cited
- → Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation(2000)529 cited